Hypera Pays $825m For Takeda LatAm Portfolio
Post-Shire Divestments Reach $7.4bn
Major new portfolio divestment, along with Deerfield site sale, form part of ongoing effort to pay down Shire-related debt and focus on novel drugs.
Major new portfolio divestment, along with Deerfield site sale, form part of ongoing effort to pay down Shire-related debt and focus on novel drugs.